Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Alexander Leads Bipartisan Support for Accelerated FDA Reviews


 

On Aug. 2, the U.S. Senate passed bipartisan legislation led by health committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.) intended to speed approval of safe drugs and medical devices.

Alexander said: "The Senate has sent to the president's desk legislation that will speed cures and treatments into patients' medicine cabinets. The first step was last year's passage of 21st Century Cures to spur medical research, and this is the next step -- ensuring patients see the benefits of those research advancements."

The legislation includes four different user fee agreements that must be reauthorized by Sept. 30. The bill is virtually identical to legislation overwhelmingly approved by the Senate's health committee on May 11. This legislation will reauthorize the authority for the Food and Drug Administration (FDA) to accept user fees - paid by manufacturers of drugs and medical devices - that account for $8 to $9 billion over 5 years and is over a quarter of all FDA funding. The reauthorizations are based on recommendations from industry and FDA after a public process.

Over the last year and a half, the HELP Committee that Alexander chairs has held 15 bipartisan briefings, including some with the House Energy and Commerce Committee, to hear from FDA and industry about the reauthorization. The HELP Committee held two bipartisan hearings, on March 21 and April 4, on the medical device and drug user fees. The committee held a markup on the bill on May 11, when two bipartisan amendments were adopted, and the committee overwhelmingly approved the bill -- voting 21 to 2.

The bill includes provisions from:

  • Sens. Isakson and Bennet to improve the medical device inspection process.
  • Sens. Hassan and Young to improve communication about abuse-deterrent opioid products.
  • Sens. Enzi and Franken to encourage medical device development for children, and make sure FDA has appropriate expertise to review devices for children.
  • Sens Roberts, Donnelly, and Burr to allow more appropriate classification of accessories used with medical devices.
  • Sens Collins, Franken, McCaskill, and Cotton to improve generic drug development and help lower prescription drug costs.
  • Sens. Hatch, Bennet, Burr, and Casey to improve access to clinical trials for all patients.
  • Sens. Bennet, Rubio, Van Hollen, and Gardner to increase the development of new drugs to treat pediatric cancers and other diseases.
 
Share:

Related Articles:


Recent Articles

Trump Picks Supreme Court Nominee

President Donald Trump announced his pick to replace Justice Kennedy on Monday evening, July 9. He selected 53-year-old Judge Brett Kavanaugh to serve on the Supreme Court, pending Congressional approval.

Read More

Before Stage Four

Providers wouldn't wait to intervene with breast cancer until it had become metastatic. Yet, delayed reaction is too often the case when it comes to suicide prevention efforts.

Read More

Nashville Fosters Innovation at Startup Day Event

The Department of Health and Human Services (HHS) is looking to invest in innovative healthcare startups, according to an official who attended the Startup Day Nashville in June.

Read More

MHAMT Leader Takes on National Role

MHA of Middle Tennessee leader Tom Starling was inducted as board chair of the national Mental Health America organization at last month's annual meeting.

Read More

The Opioid Crisis - Where Do We Go From Here?

As discussed in last month's edition of the Nashville Medical News, the Tennessee General Assembly recently approved a significant portion of Governor Bill Haslam's "TN Together" plan to combat the opioid crisis in Tennessee.

Read More

The Opioid Crisis - Where Do We Go From Here?

As discussed in last month's edition of the Nashville Medical News, the Tennessee General Assembly recently approved a significant portion of Governor Bill Haslam's "TN Together" plan to combat the opioid crisis in Tennessee.

Read More

Op-Ed: The Need for Effective Measures to Treat Mental Illness

There is an urgent need for more dynamic and effective measures to care for the growing number of Americans with serious mental illness - in Middle Tennessee and across the nation.

Read More

Behavioral Health Rounds

Read More

SAFE Clinic Opens to Victims of Sexual Violence

Nashville's first freestanding SAFE Clinic is a dedicated, healing environment for rape victims.

Read More

AAC Utilizing AI to Improve Outcomes

Artificial intelligence helping staff, patients at AAC

Read More

Email Print
 
 

 

 


Tags:
FDA, HELP Committee, Lamar Alexander, U.S. Senate
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: